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Abstract: MicroRNAs are a major category among the noncoding RNA fraction that negatively regulate gene expression 
at the post-transcriptional level, by either degrading the target messages or inhibiting their translation. MicroRNAs may 
be referred to as ‘dimmer switches’ of gene expression, because of their ability to repress gene expression without com-
pletely silencing it. Whether through up-regulating specific groups of microRNAs to suppress unwanted gene expressions, 
or by down-regulating other microRNAs whose target genes’ expression is necessary for cellular function, such as cell 
proliferation, apoptosis, or differentiation, these regulatory RNAs play pivotal roles in a wide variety of cellular processes. 
The equilibrium between these two groups of microRNA expressions largely determines the function of particular cell 
types. Our recent results with several model systems show that upon aging, there is a trend of up-regulation of microRNA 
expression, with concomitant inverse down-regulation of target genes. This review addresses molecular mechanisms that 
may provide the underlying control for this up-regulating trend, focusing on activation by various microRNAs’ own pro-
moters, through binding with pivotal transcription factors, stress response, methylation of clustered DNA domains, etc. 
Thus, epigenomic control of aging may be due in part to heightened promoter activation of unwanted microRNA expres-
sions, which in turn down-regulate their target gene products. Overriding and dampening the activation of these noncod-
ing RNAs may prove to be a new frontier for future research, to delay aging and extend healthy life-span. 
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1. INTRODUCTION 
  It has been sixteen years since the first discovery of a 
minute 22 nucleotide (nt) microRNA (miRNA), lin-4, func-
tionally characterized as regulating a target protein, lin-14, 
and controlling developmental timing in Caenorhabditis 
elegans [1]. This miRNA/target relationship was later proven 
to determine nematode life span [2], since lin-14 is an essen-
tial transcription factor (TF) with overarching impact upon a 
wide variety of signaling networks, such as the insu-
lin/insulin-like growth factor pathway [3]. This modest be-
ginning has led to an explosion in identifying not only new 
miRNAs in C. elegans, but also their orthologues in a wide 
variety of species from viruses to plants, lower animals, and 
mammals including man; altogether some 8,619 miRNAs are 
noted and catalogued in the miRBase databases (release 
12.0) [4]. It is suggested that the expression levels of more 
than 60% of human protein-coding genes are controlled by 
the 695 already identified human miRNAs [5, 6], with more 
miRNAs yet to be discovered [7]. 
  Of the total 20,000-25,000 protein-coding genes, occupy-
ing only 1.2% of the human genome, about six percent are 
functionally classified as TFs [8]. However, some 93% of 
our genome is transcribed, by far the greatest part expressed 
as non-protein-coding RNAs (ncRNA), including the miR-
NAs [9]. An order of magnitude more numerous than all the 
proteins which make up living organisms are the transcrip- 
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tion start sites (TSSs), located in promoter-proximal element 
regions, as well as an increasing number of putative pro-
moter-distal elements, identified by the pilot ENCODE pro-
ject [9]. 
  These recent findings, together with the fact that non-
protein-coding genomic sequence elements—such as miR-
NAs—predominate and are evolutionarily conserved in our 
genome, challenge our traditional understanding of the defi-
nition of a gene, which has been generally considered a unit 
of genome sequence that is transcribed to produce a protein 
product for a given cellular function. Nevertheless, as the 
ENCODE consortium suggests, a gene may be defined as “a 
union of genomic sequences encoding a coherent set of po-
tentially overlapping functional products” that eventually 
orchestrate the complex regulation and function of the host 
organism’s cellular activities [10]. An even bolder scenario 
is proposed by John S. Mattick, who suggests that the ge-
nome may consist largely of massively embedded RNA cod-
ing sequences directing regulatory networks, which may 
have co-evolved with proteins. These two complementary 
genomic sets may ultimately form the interacting RNA-
protein regulatory networks which control the complex lay-
ers of signaling communication within all cells [11, 12]. 
Thus, the intriguing notion of epigenomic regulation of es-
sential processes such as cell proliferation, differentiation, 
apoptosis, etc., characterized by feed-forward RNA regula-
tory networks, is becoming increasingly important in our 
appreciation of the epigenetic information required for the 
development of multi-cellular organisms [11]. In this report, 
we focus our discussion on the suggestion that derailment of  
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the RNA-protein interaction, and its subsequent impact on 
the regulatory networks which they direct, may constitute a 
significant fraction of the molecular mechanisms controlling 
the aging process. 
  Clearly, multicellular organisms have emerged evolu-
tionarily by means of the specialized functional states of 
various cell types; both their functions and differentiation 
lineages require complex regulation of gene expression, and 
the higher the species, the more complex this regulation [13]. 
In general, molecular mechanisms regulating gene expres-
sion may be determined by inter-related biochemical and 
molecular processes. These processes include epigenetic 
regulation [14], cis-regulatory elements such as alternative 
promoters [15], Transcription factor-dependent activation or 
repression [13, 16], mRNA-dependent actions including 
splicing, polyadenylation, and finally miRNA-dependent 
post-transcriptional regulation—including translational inhi-
bition or activation, and mRNA degradation, etc. [17-20]. 
Among the factors involved in these processes, TFs are 
probably the most important, in activating or repressing the 
expression of genes via  target binding to specific cis-
elements, TF binding sites (TFBSs), which are located 
proximal to their target’s sequence domain. Many TFBSs are 
located in clusters called cis-regulatory modules (CRMs), 
that are generally a few hundred base pairs (bp) in size, and 
may interact with more than a dozen transcription factors 
(TF). Qualitative and/or quantitative variation of these TFs 
in a given time frame and specific cell type may be dictated 
by the CRMs; the TFs and individual modules of CRM in-
teraction produce the temporospatial pattern of expression of 
the various target genes. Rather than functioning in isolation, 
TFs may cooperate or interact with each other as co-
activators or –repressors; their working partnership may 
weave the complex networks of signaling required for each 
space and time within cells [13]. 
  In the last few decades, studies of the regulation of indi-
vidual gene expressions has been primarily focused at the 
level of transcriptional control. Now this emphasis is being 
expanded to the next level of regulation, post-transcriptional 
regulation by miRNA, which shares the same simple ‘digi-
tal’ Watson-Crick sequence complementarity [11], directing 
miRNAs to post-transcriptionally repress gene expression by 
specific binding at either 3’-untranslated (UTR) or coding 
regions [17]. This principle of perfect or imperfect comple-
mentary binding results in numerous pair partnerships be-
tween individual miRNAs and their targets, giving rise to 
two molecular scenarios: a single miRNA may target hun-
dreds of messages, and vice versa the expression of any mes-
sage may be repressed by dozens of miRNAs at multiple 
binding sites [21]. This versatile miRNA/message binding 
relationship creates an exquisite system of interacting post-
transcriptional regulation of gene expression for the complex 
system-wide signaling networks needed for global program-
matic functions in each cell type, while maintaining flexibil-
ity for impromptu demands for fine tuning of segmental sig-
naling operations. 
  This notion of global versus segmental signaling controls 
prompts the suggestion, emanating from computational 
modeling, that a prevalent mechanism in both the human and 
mouse genomes is co-regulation of a given miRNA and its 
many targets. This regulation involves both positive and 
negative transcriptional regulation of the expression of both 
molecular partners [22]; within the same signaling pathway, 
participating miRNAs and their targets function in concert, 
the two entities together forming miRNA regulatory modules 
(MRMs). To date 79 such modules are defined in man, from 
data derived from expression profiles of both miRNAs and 
their target genes, as well as miRNA-target binding informa-
tion [23]. 
  As described above, transcription factors (TFs) and 
miRNAs are two prominent families of regulatory molecules 
for the control of gene expression, the former functioning at 
the transcriptional level, and the latter post-transcriptionally. 
Both species, however, share some functional similarities, 
such as binding specificity for cell type determination, plei-
otropic effect due to the abundance of miRNAs and the 
availability of a given cis-regulatory site for a particular cell 
state, cooperative and combinatoric effects of multiple miR-
NAs binding to their targets, and definition of multiple net-
works by operational motif units. It is becoming increasingly 
evident that the expression levels of many transcription fac-
tors are themselves controlled by miRNAs, such that the 
expression of miRNAs and their target TFs are linked to-
gether in an inverse relationship. In many cases, the miRNA 
and its targets function in the same signaling pathway, their 
inverse pattern of expression constituting a sensitive molecu-
lar system with feed-back loop operation to fine-tune the 
amplitude and latitude of cellular signaling [16]. An example 
of such a relationship is already reported for the miR-200 
family and ZEB1/ZEB2 [24-26]. 
  Networks of any type are generally organized in seg-
ments of functional units, connected together by ‘hubs’. The 
bigger the networks, the more single units are connected by 
‘hubs’; several such ‘hubs’ may connect together to an up-
stream ‘hub’. Thus, a larger network may be connected by a 
few major ‘hubs’, which are then individually linked to doz-
ens of minor ‘hubs’. This scenario of major and minor ‘hubs’ 
and end-point functional units creates a hierarchical order of 
network control as exemplified in Fig. (1). Evolutionarily, 
major ‘hubs’ are those most conserved across species from 
plants to animals, from lower eukaryotes to higher verte-
brates, while the minor ‘hubs’ and individual functional units 
exhibit diversity between species, and provide dynamic, 
rapid flexibility for a given species’ specialized needs. This 
hierarchical network scenario is proposed for transcription 
factor network operation, and probably pertains as well to 
miRNA functionality, albeit at the post-transcriptional level. 
Not surprisingly, miRNAs older in the evolutionary time-
scale are generally conserved, and their expression is ubiqui-
tous and abundant, while those more recently appearing in 
the phylogenetic tree are generally less abundant, serving 
specialized cell or tissue functions [13]. The suggested hier-
archical order of ‘hubs’ may be impacted by the range over 
six orders of magnitude exhibited in the levels of expression 
of various miRNAs [27]. Questions arising here, including 
how TFs and miRNAs are co-regulated, and how miRNA 
expression is regulated by TFs, are emerging as an exciting 
field of investigation. In this report, we focus on how regula-
tion by miRNA networks impacts post-transcriptionally 
many signaling processes, determining the molecular 
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II. REGULATORY NETWORKS OF MICRORNA EX-
PRESSION 
  It is by now well defined that most  miRNAs are ~22 
bases long; since they do not encode any proteins, they are 
therefore categorically known as small noncoding RNAs 
(nc-RNA). In general, mature miRNAs are formed by cutting 
off one arm of a stem-loop precursor miRNA (pre-miRNA), 
via the enzymatic reaction of a cytoplasmic RNaseIII, Dicer. 
The cytoplasmic presence of pre-miRNAs is due to their 
release from RNA polymerase (RNAP) II-transcribed long 
primary miRNAs (pri-miRNA) by a nuclear RNaseIII, Dro-
sha, in a DGCR8 complex in the nucleus; the released pre-
miRNA is then transported from the nucleus to the cyto-
plasm by Exportin5. Functionally, mature miRNAs are com-
plexed together with Argonaute (Ago), the core unit of 
RNA-induced silencing complexes (RISC) [28]. The repress-
ing of gene expression is accomplished by mature RNA di-
recting the RISC complex to bind to the target messenger 
RNA, by either perfect complementary binding, for mRNA 
degradation, or imperfect binding at the 3’UTR region, to 
inhibit translation; either modality achieves the post-
transcriptional suppression of gene expression [17, 28]. 
  Exceptions to this scenario have been noted recently: for 
example, there is evidence of transcription of a few miRNAs 
by RNAP III; these miRNAs are separated by interspersed 
Alu repeats [29, 30**]. In addition, Drosha-independent 
processing may be seen with pre-miRNAs found in intron 
regions, termed ‘mirtrons’; they are processed instead by 
nuclear pre-mRNA splicing [31-33]. There is also another 



















Fig. (1). An example of a signaling network for peroxide-induced premature senescence in human fibroblasts, demonstrating major 
and minor ‘hubs’; the former are possible target sites of five different putative microRNAs. This network was constructed by the Inge-
nuity functional clustering software, with lead proteins identified as differing in concentration between young replicating WI-38 human fi-
broblasts and their senescent counterparts exposed to peroxide, and their prematurely senescent counterparts (induced by peroxide). The five 
major hubs, represented here as yellow color-filled circles, are: High-mobility group box 1 (HMGB1), Annexin A2 (ANXA2), Vimentin 
(Vim), Heat-shock protein B1 (HSPB1 or Hsp27), and Stress-induced phosphoprotein (STIP1); and the two minor hubs, represented here as 
two gray color-filled circles, are histone 1 (H4d) and interleukin (IL). In this model each of the five major hubs is targeted by one of five 
putative microRNAs, i.e. miR-X, miR-Y, miR-, miR-, and miR-. However, not shown here are the two potential scenarios that: 1. an 
individual ‘hub’ may be targeted by multiple microRNAs; and 2. miR-X may target not only HMGB1 but also HSPB1, according to the 
multi-miR/multi-target pair principle.  Epigenetic Control of MicroRNA Expression and Aging  Current Genomics, 2009, Vol. 10, No. 3    187 
derived miRNA from nonmirtronic genomic loci [33]. These 
few examples serve to show that many exceptions to the rule 
exist, and undoubtedly many more new mechanisms remain 
yet to be discovered. 
  The production of functional miRNAs, from the initial 
transcription of the miRNA genes in the nucleus to the gen-
eration of mature miRNA in the cytoplasm, may be subject 
to many levels of regulation [28]. For example, nearly iden-
tical mature miRNAs may be generated from different mem-
bers of the same miRNA gene family; the distinction among 
members is determined by the pre-miRNA loop nucleotide 
sequences. Since these sequences are the essential elements 
for Dicer activity before transforming the pre-miRNAs into 
mature miRNAs, sister members of a large miRNA gene 
family may be orchestrated for different required signalings 
[28]. Thus, the complexities in the biogenesis of miRNA are 
yet compounded by another layer of regulation, i.e. the pre-
miRNA stem-loop sequences. In this report, we focus on the 
regulation of miRNA biogenesis at its first step, regulation 
by TFs, with the realization that subsequent steps controlling 
mature miRNA expression are also essential for the putative 
post-transcriptional regulation of signaling for the aging 
process. 
miRNA Genomics and Gene Structure 
  Nearly half of the loci for mammalian miRNAs are lo-
cated in close proximity to each other, often in a cluster se-
quence domain, with a ‘master’ promoter for the production 
of a single polycistronic transcription unit (TU). The remain-
ing miRNA loci may then be structured as individual units, 
each controlled by its own separate promoter element. Ap-
proximately 40% of miRNA loci are located in the intronic 
region of non-coding transcripts, and ~10% in the exonic 
region of non-coding TUs; ~40% appear within introns of 
protein-coding genes. Alternative splicing actions determine 
whether a miRNA is intronic or exonic, with some miRNA 
genes located in either region [28]. The mature miRNAs 
coded by clustered polycistronic transcripts may be either 
functionally related or distinct [34]. Lengthwise, most inter-
genic human pri-miRNA genes measure some 3-4 kb, with a 
distinct 5’- TSS and a CpG island located within the up-
stream proximal 2 kb region, and also flanked by a poly(A) 
site within the downstream 2 kb region of the embedded pre-
miRNA code. The TFBSs for pri-miRNAs are often found in 
clusters within the upstream 2 kb region of the pre-miRNAs; 
the TFs controlling signaling for growth and development 
are predicted by bioinformatic models to target these clusters 
[35]. Surprisingly, the length distributions of the two groups 
of polycistronic and singleton pri-miRNAs are quite similar: 
half of both groups measure between 1 and 10 kb, most of 
the remainder of the predicted polycistronic pri-miRNAs are 
tens of kb long, with a few putative pri-miRNA genes with 
expanded length up to hundreds of kb. This length distribu-
tion for miRNA genes differs from that of protein-coding 
TUs; in general, the mean length of a protein coding TU for 
a message is ~50 kb long, and those containing intronic 
miRNAs are even longer, exceeding 150 kb. As with pro-
tein-coding TUs, about half (54%) of the predicted pri-
miRNA genes exhibit both promoter and other regulatory 
sequences, as well as organized exon-intron structural do-
mains, although with fewer intron regions than in protein-
coding TUs [36]. 
Promoters of MicroRNA Genes 
  MicroRNA genes are mainly transcribed by RNAPII, and 
are thus believed to share characteristics and regulation 
mechanisms of a class II gene. The promoter region of a 
class II gene is usually separated into three compartments: 
(1) a ~100 bp long core promoter domain, with TSSs for 
binding by RNAPII, and binding sites for the general tran-
scription factor (GTF), embedded within it; (2) immediately 
upstream to this region, a proximal domain several hundred 
bp long, containing primary specialized regulatory elements; 
and (3) distal domains, thousands of bp long, constituting 
secondary regulatory elements [37]. In general, initiation of 
transcription is activated by RNAPIIs binding to their spe-
cific target binding sequence elements within the core pro-
moter. Two different types of core promoters are defined, 
focused and dispersed; the former contain either a single 
TSS or a unique cluster of TSSs several nucleotides (nt) in 
length, while the latter contain several TSSs over 50–100 nt, 
and are typically embedded in CpG islands in vertebrates. 
Evolutionarily, focused promoters are more conserved, 
found in abundance in both invertebrates and vertebrates; 
however, within the vertebrate kingdom, dispersed promot-
ers are more commonly identified than the focused type. 
Assemblies of general sequence motifs are often found 
within the core promoters, including familiar elements such 
as TATA box, BRE (TFIIB recognition element), Inr (Initia-
tor), MTE (motif ten element), DPE (downstream core pro-
moter element), DCE (downstream core element), and 
XCPE1 (X core promoter element 1). Combinatoric regula-
tion through the differential binding of these diverse ele-
ments supports the versatile control mechanism required for 
appropriate transcription, response to enhancers, etc. [38]. In 
silico  predictions suggest that typical TATA-box elements 
exist in the core promoter regions of a third of all human 
miRNA genes [39]. Wet lab experimentation combined with 
bioinformatic studies establish that these motifs are also 
found within miRNA genes, demonstrating the intricate ex-
pression required for various cellular signaling. Similar to 
known protein-coding genes, about 64% of promoters of 
miRNAs possess CpG islands within the 500 bp proximal 
region. Also, TATA elements are found within 19% of 
miRNA gene promoters, BRE elements in 21%, Inr elements 
in 47%, MTE in 7%, and DPE in 87%. This description at-
tempts to show that miRNA TSSs identified so far share 
similar sequence properties with protein-coding genes 
[30**]. 
  Since most miRNA genes are transcribed by RNAPII, 
they may be subject to the same regulatory rules as pertain in 
the transcription of protein-coding TUs. This regulatory mo-
dality usually involves the recruitment of RNAPII to the 
target DNA-binding region, along with various general tran-
scription factors (GTFs), such as TFIIB, TFIID, TFIIE, 
TFIIF and TFIIH, to form the pre-initiation complex (PIC) 
which supports binding to specific sites in the promoter do-
mains, enabling subsequent transcription initiation, followed 
by triage to either promoter escape for abortive transcription, 
or elongation and finally transcription termination for suc- 
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cessful transcription. Integrated in this step are many regula-
tory factors to facilitate or repress the operation of the PIC at 
the target binding sites [40]. Key to the entire transcription 
initiation, recruitment, and formation of co-activator or co-
repressor complexes are cis-acting sequence domains em-
bedded either in the core promoter regions or in the pri-
mary/secondary distal locations, and functionally manifested 
as either enhancing or repressing elements for transcription 
[38]. 
  Identification of TF binding properties for the regulation 
of miRNA transcription has been hampered until recently by 
dependence upon isolating transient pri-miRNA transcripts 
from a given cell type, which may or may not contain the 
entire TF-binding sequence information. A recent approach 
to solving this problem is the emerging notion that histone 
modification of DNA is frequently observed at sites of tran-
scription initiation and elongation. In particular, the trimeth-
ylation of histone H3 at its lysine 4 residue (H3K4me3)   
occurs at the TSSs of most genes in the genome; this cova-
lent modification of histone H3 is generally found only at 
sites of transcription initiation [41]. After mining data gener-
ated from many cell types for H3K4me3-enriched loci,   
Marson et al. generated a library of possible TSSs for both 
human and mouse genomes. By incorporating these signa-
ture H3K4me3 sites with the locations of CpG islands and 
ESTs within the 250 kb upstream regions of individual 
miRNA genes, they predicted promoter regions in ~1 kb 
resolution for 294 human pri-miRNAs, which give rise to 
441 mature miRNAs [42**]. 
  This strategy of computational biology is validated ex-
perimentally by integrating the knowledge that TSSs are in 
general free of nucleosomes; a 100 to 130 bp window lack-
ing nucleosome binding is usually found to surround the 
TSSs [43]. Using chromatin immunoprecipitation (ChIP) on 
chip (ChIP-chip) with one breast cancer and two melanoma 
lines, Ozsolak et al. screened for TSSs within 20 kb up-
stream and 1kb downstream of all miRNAs, by searching for 
the binding of H3K4me3, H3K9/14Ac (acetylation of Lys 
9/14 of histone 3), RNAPII, and RNAPIII. Their results 
identify TSSs for 175 human miRNA genes, as well as a 
short (~70 bp) nucleosome-depleted domain within the core 
promoter region [30**]. Interestingly, some intronic miR-
NAs contain TSSs different from those of the host messages 
in which they are embedded, suggesting that miRNA genes 
may be transcribed either by their host genes’ TSSs, or inde-
pendently by their own distinct TSS activation. Variable 
distances, ranging from a few hundred bp to 20 kb, are found 
between the start sites of transcription and the coding region 
of miRNAs [30**]. 
Transcription Factors Binding MicroRNA Promoters 
  Four transcription factors, Oct4, Sox2, Nanog and Tcf3, 
determine the pluripotent and self-renewing properties of 
embryonic stem (ES) cells. Interestingly, these four factors 
occupy 55 unique miRNA TUs in mouse ES cells; the fact 
that these 55 miRNA TUs give rise to 81 mature miRNAs 
suggests that about 20% of known mammalian miRNA 
genes are controlled by these four TFs. The same percentage 
of protein-coding genes depends on these four factors for 
their promoter regulation. During differentiation, Oct4 and 
Nanog are silenced in ES cells, and consequently a signifi-
cant fraction of their target miRNAs are down-regulated 
100- to 1000-fold. A quarter of miRNA genes bound by 
Oct4/Sox2/Nanog/Tcf3 are not actively transcribed in ES 
cells, as their promoters are co-occupied by epigenetic regu-
latory Polycomb group (PcG) proteins, which catalyze 
H3K27me3 methylation to repress transcription, and thus 
control specific target gene expressions needed for differen-
tiated cells [42**]. 
  Investigators of the Ozsolak group proceeded from their 
knowledge of TSSs to investigate the possible existence of 
well-known transcription elements such as E-box elements 
within the promoter regions of miRNA genes. Among the 
many factors binding to E-box elements is the recognized 
melanoma oncogene, MITF, functionally characterized as 
the master switch for melanocyte development. Ten E-boxes 
found in 9 miRNA genes are bound by MITF in a melanoma 
cell line. Besides MITF, binding to the E-box of miRNA 
genes is also seen with c-Myc, CREB (cyclic AMP-
responsive element binding protein), Suz12 (suppressor of 
zeste 12 homolog, a PcG protein), and PPAR (peroxisome 
proliferator-activated receptor) [30**]. 
  Aside from the high-throughput screening approach to 
identify miRNA promoter regions and the TFs potentially 
binding to them, many reports take the approach of individ-
ual miRNA gene-based investigation. For example, the E-
box promoter is found in the 7.9 kb ncRNA transcript re-
gions of miR-199a and miR-214 clusters embedded in the 
Dynamin-3 gene intron domain [44]. Functionally, aside 
from its pro-proliferation properties, c-Myc suppresses 13 
miRNA genes controlled by 21 unique TUs [45]; c-Myc up-
regulation is also associated with the pro-tumorigenic nature 
of the miR-17-92 cluster [46]. Several groups have shown 
that members of the miR-34 family are directly controlled by 
p53, which induces apoptosis, cell cycle arrest, and senes-
cence [47]. 
Predominant Up-Regulation of MicroRNAs During Ag-
ing 
  By array profiling of global miRNA expression, our re-
sults show more miRNAs up-regulated than down-regulated 
during aging. miRNA expression levels were profiled in the 
livers of 4, 10, 12, 18, and 33 month old C57/Black mice. 
Among the up-regulated miRNAs identified, the levels of 
miR-669c and -709 start to increase at 18 months, the mid-
life of the mouse lifespan, and reach maximal levels at 33 
months. This trend is not observed for miR-93 and -214, 
which show significant up-regulation only at 33 months, 
extreme old age for mice; we identified very few miRNAs 
significantly down-regulated with age [48]. 
  Why are more miRNAs up-regulated with age, and what 
are the underlying mechanisms controlling this up-
regulation? We suggest that the main factor may be aberrant 
control of TFs binding at the promoter region of key up-
regulated miRNAs. For example, the transcription start site 
for mmu-669c was first identified by Marson, et al. 2008, 
and reported in their supplementary table [42**]. The gene 
for mmu-miR-669c is located in one intron of the gene, 
Sfmbt2 (Scm-like with four mbt domains 2), a PcG protein, 
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yang1 (YY1), possibly forming a PcG silencing complex. 
Embedded in this intron is a large cluster of more than a 
dozen microRNAs, including miR-669c [49]. Three CpG 
islands reside in the proximal region of mmu-miR-669c; the 
first contains a candidate TSS, 137 kb upstream from mmu-
669c [49]. This embedding of a large cluster of miRNAs 
with their own transcription unit is feasible because the host 
gene, sfmbt2, is extremely long, 225 kb, but its own tran-
scripts only take up 7.7 kb, leaving plenty of space for the 
miRNA gene cluster [49]. The gene for the other miRNA 
showing mid-life up-regulation, mmu-miR-709, is found in 
intron 8 of transcription factor Rfx1 (regulatory factor for X-
box 1); the TSS is located in a CpG island. Functionally, 
Rfx1 is involved as a TF in the activation of gene expression 
for viruses, including human hepatitis B virus and cytomega-
lovirus, while suppressing cellular genes such as c-myc and 
the proliferating cell nuclear antigen. Rfx1 also mediates the 
serum-induced immediate early response of Id2 (inhibitor of 
DNA binding/differentiation) expression, by binding to the 
TSS of Id2 [50]. Mmu-miR-709 also targets the protein en-
coded by a gene called Brother of the Regulator of Imprinted 
Sites (BORIS), an important regulator of DNA methylation 
and imprinting. Tamminga et al. showed that in testis, X-ray 
irradiation causes DNA damage-induced, and Rfx1-media- 
ted, increase of miR-709 expression; this may function as a 
protective mechanism to reduce the level of BORIS in cells, 
so as to prevent massive aberrant DNA methylation, etc. [51]. 
Stress-Responsive miRNAs 
  Perhaps the accumulation of stress and its deleterious 
consequences is the most popular theory to explain age-
dependent decline [52]. Not surprisingly, miRNAs as the 
post-transcriptional control for gene expression are intrinsi-
cally linked to the functional decline, and the aberrant sys-
tem homeostasis, during aging. Stress-induced impact on 
miRNA biogenesis may induce a cascade of downstream 
molecular and biochemical aberrancy, precipitating the phe-
notypic manifestations seen in aging organisms. Among the 
many steps involved in the biogenesis of mature miRNAs, 
Dicer is exquisitely sensitive to these insults; its function is 
inhibited by stresses including reactive oxygen radicals, ex-
posure to phorbol esters, and action of Ras oncogene [53]. In 
HeLa cells, TNF (tumor necrosis factor )-induced rapid 
apoptotic death is accompanied by the down-regulation of 
Dicer, suggesting the apoptosis-associated cellular insults 
impacting on the decreased level of this enzyme, which in 
turn may affect the biogenesis of mature miRNAs [54]. 
  MicroRNA-210 and -373, induced as a cellular response 
to hypoxic stress, function to dampen the level of key pro-
teins involved in DNA repair, and the observed genetic in-
stability in cancer cells [55]. To date, the best studied stress-
responsive factor for miRNA expression is the transcription 
factor hypoxia-inducible factor-1, (HIF-1), known to tar-
get the miR-17-92 cluster [56]. HIF-1 also activates miR-
210 [57]; in human breast cancer cells, over-expression of 
hsa-miR-210 is induced by hypoxia, dependent on the func-
tion of HIF-1 and VHL (von Hippel-Lindau syndrome pro-
tein, involved in the ubiquitylation and degradation of HIF) 
[58]. A substantial number of miRNAs are up-regulated by 
exposure to low oxygen environment, including miR-23, -24, 
-26, -27, -103, -107, -181, -210, and -213; some of these up-
regulations are HIF-dependent. In addition, within this 
group, miR-26, -107, and -210 decrease pro-apoptotic signal-
ing upon exposure to hypoxic environment; thus these miR-
NAs may indirectly affect tumor formation, by allowing 
cancerous cells to survive. Not surprisingly, a significant 
number of hypoxia-induced miRNAs are also over-expressed 
in many human tumors [59]. 
  Known for years as the ‘guardian of the genome’, p53 is 
activated in response to assorted insults including DNA 
damage, depletion of dNTP, low-oxygen hypoxia conditions, 
and even the effect of oncogenes. Up-regulation of p53 is 
induced indirectly by miR-29 family members; this is due to 
the fact that this microRNA represses the negative regulators 
of p53, p85 and CDC42 [60]. p53 also activates the expres-
sion of the miR-34 family, which in turn suppresses the cy-
clin-dependent kinases required for cell cycle traverse [47]. 
Halting cell cycling at either G1 or G2 checkpoints is also 
associated with genotoxic, stress-dependent p53 activation, 
up-regulating homologous tumor suppressor miR-192/215, 
which functionally targets gene expressions needed for the 
traverse of these two checkpoints of cell cycle traverse [61]. 
Other targets of miR-34, including SIRT1 protein, etc., are 
described in detail in the chapter in this issue by Apana 
Takwi and Yong Li titled “The p53 pathway encounters the 
microRNA world”. 
  Hypertrophy of adult cardiomyocytes may be induced by 
many forms of injury and stress, perhaps due to over-
expression of several stress-responsive miRNAs, including 
miR-23a, -23b, -24, -195, and -214. Likewise, specific over-
expression of miR-195 induces cardiac hypertrophy to the 
extent of causing heart failure in transgenic mice [62]. 
Within intron 27 of -myosin heavy chain (MHC) is em-
bedded cardiac-specific miR-208, linked to cardiomyocyte 
fibrosis and hypertrophy, and expression of MHC. Mice 
deficient for miR-208 are short-lived after birth, due to pro-
gressive heart failure and inappropriate up-regulation of fast 
skeletal muscle and stress response genes [63]. 
  Another stress-responsive TF/miRNA gene pair may be 
NF-B and hsa-miR-146a. In Alzheimer’s disease brain, up-
regulation of has-miR-146a is found in inverse relationship 
with the down-regulation of its target gene, complement fac-
tor H (CFH), which is an important repressor of inflamma-
tory response in the brain. In primary cultures of oxidatively 
stressed human neural cells, treatment with interleukin-1 
and/or A42 increases the expression of NF-B. The activa-
tion of miR-146a is controlled by NF-B through binding to 
three different target domains of this miRNA’s promoter 
[64]. Since miR-146a also targets TNF receptor-associated 
factor 6 (TRAF6) and IL-1 receptor associated kinase 
(IRAK1), and since both of these can activate downstream 
NF-B, this forms yet another feed-back loop between a TF 
and miRNA gene expression [65]. Thus, NF-B activates the 
production of miR-146a, which suppresses the TRAF6 and 
IRAK1 required for its activation, an intricate mechanism 
ensuring the balanced expression of NF-B at the desired 
level in cells. 
  One of the most consistently observed declines encoun-
tered during aging is stress attenuation: the robustness of the 
response to stress is diminishing in aged animals. Therefore, 
maintaining reduced levels of stress-responsive gene expres-190    Current Genomics, 2009, Vol. 10, No. 3  Liang et al. 
sion allows an ample reservoir to respond to sudden needs. 
Hsa-miR-20a, -93, -106b, -373, and -520d repress the ex-
pression of MICA and MICB, functioning as stress-activated 
ligands recognized by receptor NKG2D; the ligand and re-
ceptor are involved in the removal of tumor cells and invad-
ing virus particles. Since exposure to many insults, including 
heat shock, oxidative stress, viral infection, and DNA dam-
age, induce up-regulated MICA and MICB expression, con-
stitutive repression of these two proteins’ abundance to 
lower levels should permit their rapid acute activation when 
needed. Thus, the function of these miRNAs may be viewed 
as defending stress attenuation. However, excessive over-
expression of these miRNAs, as in neoplasia, induces the 
inability to form the NKG2D complex needed for the re-
moval of the tumor cells [66]. Again, this suggests the need 
to have miRNA expressions balanced at the proper threshold 
levels, allowing the avoidance of stress attenuation without 
the loss of tumor removal capability in the immune system. 
Epigenetic Regulation of miRNA Expression 
  Among the many biochemical controls of epigenetic im-
pact in gene expression, DNA methylation may be the most 
dominant. Since DNA methylation is intimately involved 
with histone modification, it is not unreasonable to suggest 
that the post-translational modification of histone and its 
associated partners may also be vital factors governing the 
success of transcriptional outputs needed to achieve the cel-
lular signaling required for many biological events, such as 
cell cycle traverse, apoptosis, response to environmental 
insults, etc. [14]. 
  Most DNA modification involves covalent modification 
by methylation at the cytosine bases of CpG dinucleotides, 
the backbones of CpG islands. Hypermethylating the CpG 
islands in the promoters of miRNAs suppresses their tran-
scription, perhaps by interacting with methyl-CpG-binding 
proteins (MeCPs). In addition, DNA methylation in mam-
malian cells is largely dictated by three major protein com-
ponents, Dnmt1, Dnmt3A, and Dnmt3B, of the DNA meth-
yltransferase (DNMTs) family [14]. Obviously, methylation 
of miRNA promoters may be pivotal to determining the abil-
ity of miRNA transcripts to be successfully produced, and 
dys-regulation of this biochemical event may induce the loss 
of essential miRNAs, and subsequent pathological develop-
ments in tissues. This scenario is mostly noted in cancer. 
Aberrant hypermethylation is found in the genes of mir-9-1, 
-124a3, -148a, -152, and -663 in many human breast cancer 
tissues [67]. Treating lymph node-derived metastatic cancer 
cells with inhibitors of DNA methylation such as 5-aza-2’-
deoxycytidine induces up-regulation of the expression of 57 
miRNAs, among which 27 bear characteristic CpG islands in 
their promoter regions; 16 of these 27 exhibit hypermethy-
lated CpG islands, typical of cancers, while the remaining 11 
miRNAs’ CpG islands are equally hypermethylated in can-
cerous and normal cells. Notwithstanding the importance of 
methylation at CpG islands, miRNA-directed post-trans- 
criptional regulation of other factors such as the three meth-
yltransferases [68, 69] may be indirectly linked to the methy-
lation status of miRNA promoters, and therefore their activa-
tion. Clearly, methylation at CpG islands of miRNA promot-
ers is a fertile field of research for the study of aging; future 
work should elucidate whether age-dependent qualitative 
and/or quantitative impact of this biochemical event precipi-
tates the up-regulation of specific miRNAs in aged animals. 
III. CONCLUSION AND PERSPECTIVE 
  Our recent findings from several aging model systems 
can be summarized as: 1. during aging, predominantly up-
regulated miRNA expression is observed; 2. in liver, this up-
regulated trend emerges at 18 months, the mid-life of a 
mouse’s life span; and 3. parallel proteomic profiling and 
bioinformatic mapping show that the up-regulated miRNA 
expression corresponds to the down-regulation of genes 
functionally involved in the control of intermediate metabo-
lism, apoptosis, DNA repair, oxidative defense, particularly 
mitochondrial oxidative phosphorylation, etc. In addition, 
our work with cultured fibroblasts shows that stress, such as 
peroxide treatment, can induce the trend of up-regulating 
miRNA expression. In particular, permanent growth arrest, 
seen either in replicative senescence via serial passaging, or 
in premature senescence induced by peroxide treatment, is 
associated with significant up-regulated expression of miR-
NAs. These culture models suggest that in stress-dependent 
activation of miRNA up-regulation, as in tissues during ag-
ing, accumulation of stress may be a major factor inducing 
the same up-regulating trend. 
  Clearly, emerging from the above description is the obvi-
ous question, why and how during aging is miRNA expres-
sion up-regulated? The answers may lie in at least three ar-
eas,  i.e. transcription factors (TFs), stress response, DNA 
methylation, etc. (Fig. 2). TFs have long been known to be 
essential to the expression of key genes which accelerate or 
delay the aging process. Interestingly, these TFs may them-
selves functionally regulate the very miRNAs that target 
their expression, thus forming feed-back loops between the 
two molecular categories. Moreover, the acetylation status of 
these factors may introduce another layer of control for their 
function. Thus, dysregulation of the balanced expression 
between miRNAs and their target TFs may then be the very 
molecular force driving the disequilibrium of many cellular 
processes seen during aging. Notwithstanding the impor-
tance of miRNA/TF loops in controlling the aging process, 
the fact that most miRNA genes are found in clusters, and a 
single promoter element can control both the proximal and 
distal sequence domains of these ncRNAs, introduces an-
other layer of complexity, i.e. the DNA methylation and his-
tone modification of these genomic domains, dictating the 
folding and unfolding of the necessary structural features for 
gene expression. Moreover, the stability and repair of pro-
moter DNA structures emerge as essential up-stream factors 
determining the proper expression of miRNAs. Stress-
induced damage in these regions, to either genomic DNA or 
the proteins that bind to them, may equally impact promoter 
regulation, thus inducing deleterious miRNA up-regulation 
during aging. In all, DNA methylation, histone modification, 
and DNA repair are essential biochemical processes, neces-
sary to maintain proper patterns of miRNA expression; fac-
tors involved in these three processes, thus controlling 
miRNA expression, along with the miRNAs themselves, 
have evolved as ‘Epigenomic Regulators of the Aging Proc-
ess’. Future research in this area should yield unprecedented 
new insights as to how the aging process is controlled epige-
nomically. Epigenetic Control of MicroRNA Expression and Aging  Current Genomics, 2009, Vol. 10, No. 3    191 
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Fig. (2). Suggested model for the regulation of miRNA expression. MicroRNA expression may be regulated at both transcriptional and 
post-transcriptional levels. Step i: transcription activation or repression by DNA and/or histone modification, for binding by transcription 
factors (TFs) for either activating or repressing the promoter elements of the microRNA gene clusters; Step ii: transcription of miRNA gene 
by RNA polymerase II (RNAP II) and/or RNA polymerase III (RNAP III); Step iii: putative factors regulating RNAP functions for initia-
tion, elongation, and termination steps of microRNA gene clusters; Step iv: export of the primary transcripts of miRNA (pri-miRNA), fol-
lowed by further processing to become precursor microRNA (pre-miRNA), which are exported from the nucleus to the cytoplasm; Step v: in 
the cytoplasm, pre-miRNAs are processed further to mature miRNAs, which can then silence the target message’s expression.  192    Current Genomics, 2009, Vol. 10, No. 3  Liang et al. 
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